INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,311,596 | -21.5% | 1,389,296 | 0.0% | 0.32% | -41.1% |
Q2 2023 | $56,474,882 | +9.4% | 1,389,296 | 0.0% | 0.55% | -85.7% |
Q1 2023 | $51,605,400 | +81.8% | 1,389,296 | +68.2% | 3.82% | +206.8% |
Q4 2022 | $28,391,785 | +69.8% | 826,063 | +184.3% | 1.24% | +149.8% |
Q3 2022 | $16,723,000 | -0.7% | 290,528 | -12.6% | 0.50% | +1.0% |
Q2 2022 | $16,839,000 | +108.3% | 332,384 | +198.1% | 0.49% | +30.4% |
Q1 2022 | $8,084,000 | – | 111,515 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |